Tag Archives: amid

‘New GSK’ shows strength amid investor pressure, but Shingrix still needs to regain its footing

As activist investor Elliott Management turns up the heat on GlaxoSmithKline, CEO Emma Walmsley’s new vision for the company is showing strength. But while Glaxo’s vaccines business does gangbusters overall, its crown jewel Shingrix has yet to hit its stride after the pandemic knocked it off its course. GSK’s shingles vaccine reeled in £295 million… Read More »

OSHA standard compliance date arrives amid confusion, industry pushback

Dive Brief: Healthcare facilities must be in full compliance with the Occupational Safety and Health Administration’s Emergency Temporary Standard as of Wednesday, including requirements around ventilation, physical barriers and training. The American Hospital Association, Association of American Medical Colleges and other groups had pushed the agency to delay compliance dates, contending providers needed more time… Read More »

Iraq pushes vaccine rollout amid widespread apathy, distrust

BAGHDAD — Iraq’s vaccine roll-out had been faltering for weeks. Apathy, fear and rumors kept many from getting vaccinated despite a serious surge in coronavirus infections and calls by the government for people to register for shots. It took a populist Shiite cleric’s public endorsement of vaccinations — and images of him getting the shot… Read More »